Search
Moroctocog alfa
go.drugbank.com/drugs/DB13999ApprovedMoroctocog alfa is approved by Health Canada and by the European Medicines Agency for the control and prevention of hemorrhagic episodes and for routine and surgical prophylaxis in patients with hemophilia … Replacement of Factor VIII is essential for the treatment of Hemophilia A, which is caused by mutations in the Factor VIII gene, leading to a functional deficiency or complete loss of protein.
Products: Xyntha Powder and Solvent for Solution for Injection 250iu, Xyntha Powder and Solvent for Solution for Injection 500iuAlirocumab
go.drugbank.com/drugs/DB09302ApprovedInvestigationalAlirocumab is a biopharmaceutical that obtained FDA approval in July 2015 as a second line treatment for high cholesterol in adults whose LDL-cholesterol (LDL-C) is not controlled by the combination of
Categories: Hypolipidemic Agents Indicated for Hyperlipidemia, Non-statin Hypolipidemic Agents Indicated for HyperlipidemiaProducts: PRALUENT 150 MG/ML (SOLUTION FOR INJECTION IN PRE-FILLED PEN), PRALUENT 75 MG/ML (SOLUTION FOR INJECTION IN PRE-FILLED PEN)Peginterferon alfa-2b
go.drugbank.com/drugs/DB00022ApprovedInvestigational-2b for the treatment of Hepatitis C [A19593]. … HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients [L852].
Categories: Treatments for Hepatitis C, Compounds used in a research, industrial, or household settingProducts: PEG-INTRON CLEARCLICK FOR INJECTION 80 mcg/0.5 ml, PEG-INTRON CLEARCLICK FOR INJECTION 100 mcg/0.5 mlTuroctocog alfa
go.drugbank.com/drugs/DB09109ApprovedTuroctocog alfa is a recombinant factor VIII (rFVIII) with a truncated B-domain made from the sequence coding for 10 amino acids from the N-terminus and 11 amino acids from the C-terminus of the naturally … Turoctocog alfa is produced in Chinese hamster ovary (CHO) cells without addition of any human- or animal-derived materials.
Products: NOVOEIGHT POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 500IU/VIAL, NOVOEIGHT POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 250IU/VIALSalicylic acid
go.drugbank.com/drugs/DB00936ApprovedInvestigationalVet approvedA compound obtained from the bark of the white willow and wintergreen leaves, and also prepared synthetically. It has bacteriostatic, fungicidal, and keratolytic actions. Its salts, the salicylates, are used as analgesics.
Mixtures: Anti-acne Formula for Men, Sastid Soap for Stubborn AcneCategories: Antifungals for Topical Use, Antifungals for Dermatological UseTeprotumumab
go.drugbank.com/drugs/DB06343ApprovedInvestigationalmultiple invasive surgeries - teprotumumab is the first drug ever approved for the treatment of TED and therefore represents a significant step forward in the treatment this disease. … which its efficacy in the treatment of thyroid eye disease (TED) was assessed, it received "breakthrough therapy" designation from the FDA in 2016[A190129] and was approved by the FDA in January 2020 for
Products: TEPEZZA 500 MG/VIAL POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSIONMeropenem
go.drugbank.com/drugs/DB00760ApprovedInvestigationalIn August 2017, a combination antibacterial therapy under the market name vabomere was approved for treatment of adult patients with complicated urinary tract infections (cUTI). … The treatment aims to resolve infection-related symptoms and achieve negative urine culture, where the infections are proven or strongly suspected to be caused by susceptible bacteria.
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseProducts: MEPRONEM POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/VIAL, Pospenem Powder for Solution for Injection 1gDiphenhydramine
go.drugbank.com/drugs/DB01075ApprovedInvestigationalmedications that have been marketed for "night time" use [L5263, L5281, L5287]. … As a result, diphenhydramine is being investigated for its anxiolytic and anti-depressant properties.
Mixtures: Benylin for Children All-IN-one Cold & Fever Nightime, Only For BODY PAINCategories: Antihistamines for Topical Use, Antihistamines for Systemic UseCefepime
go.drugbank.com/drugs/DB01413ApprovedInvestigationalFDA approved cefepime in combination with zidebactam, a beta-lactamase inhibitor, for the treatment of adults with complicated urinary tract infections, including pyelonephritis.[L63350, L63932] … [A2457,A249050] Cefepime is normally used to treat severe nosocomial pneumonia and infections caused by multi-resistant microorganisms such as _Pseudomonas aeruginosa_, and is also indicated for the empirical
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseProducts: Cefevon powder for solution for injection 2g/vial, ROXIPIME POWDER FOR SOLUTION FOR INJECTION 2G/VIALCarfilzomib
go.drugbank.com/drugs/DB08889ApprovedInvestigationalFDA approved carfilzomib in July 2012 for the treatment of adults with relapsed or refractory multiple myeloma as monotherapy or combination therapy.[L39392]
Products: KYPROLIS POWDER FOR SOLUTION FOR INFUSION 60MG/VIAL, KYPROLIS POWDER FOR SOLUTION FOR INFUSION 30 MG/VIAL